[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 698
Citations 0
Clinical Trials Update
November 22/29, 2016

Human Milk Protein Prevents Infections in Preterm Infants

JAMA. 2016;316(20):2078. doi:10.1001/jama.2016.17037

Diseases that affect premature infants in neonatal intensive care units are usually caused by hospital-acquired infections. Breast milk protects against infection by modifying the intestinal microbiome and boosting systemic immunity, but maternal colostrum is limited when infants are extremely preterm. According to a recent trial in The Journal of Pediatrics, feeding extremely low-weight preterm infants recombinant human lactoferrin talactoferrin (TLf), a human milk protein, was safe and resulted in fewer infections compared with placebo.